{"_id":"agxzfmlsbGlzdHNpdGVyGAsSC05ld19Db21wYW55GICAkKztwq4LDA","founded_year":1994,"lastupdate":"2024-12-05T00:00:00.000Z","update_date":"2024-12-05T00:00:00.000Z","lastModified":"Jan 28, 2025","confidence_score":68,"active":1,"confidence_score_reason":"product stage, sector, business model, video or image, funding rounds, markets, not claimed","urlname":"integer-holdings-corporation","minimal_profile":null,"status":"Public","fullstatus":"Public on NYSE on Sep, 2020;","acquired":0,"description_edited":0,"tag_line_edited":0,"phone":"","registrar":"","biverification":"Maor Perlov","recentupdates":[{"email":"eranl@sncentral.org","source":"Automatic","datetime":"2024-12-22 06:26:45.000000","last_name":"Levin","first_name":"Eran"},{"email":"maor.perlov@sncentral.org","source":"Manual","datetime":"2023-12-12 19:40:22.000000","last_name":"Perlov","first_name":"Maor"},{"email":"maor.perlov@sncentral.org","source":"Manual","datetime":"2023-12-12 19:40:21.000000","last_name":"Perlov","first_name":"Maor"},{"email":"eranl@sncentral.org","source":"Automatic","datetime":"2024-01-25 08:03:03.000000","last_name":"Levin","first_name":"Eran"},{"email":"eranl@sncentral.org","source":"Automatic","datetime":"2024-02-13 06:54:27.000000","last_name":"Levin","first_name":"Eran"},{"email":"eranl@sncentral.org","source":"Automatic","datetime":"2024-12-05 14:53:31.000000","last_name":"Levin","first_name":"Eran"},{"email":"maor.perlov@sncentral.org","source":"Manual","datetime":"2023-12-12 19:40:21.000000","last_name":"Perlov","first_name":"Maor"},{"email":"eranl@sncentral.org","source":"Automatic","datetime":"2024-12-05 15:12:17.000000","last_name":"Levin","first_name":"Eran"},{"email":"maor.perlov@sncentral.org","source":"Manual","datetime":"2023-12-12 19:38:05.000000","last_name":"Perlov","first_name":"Maor"},{"email":"eranl@sncentral.org","source":"Automatic","datetime":"2024-08-07 05:51:13.000000","last_name":"Levin","first_name":"Eran"},{"email":"jenny.sotnik@sncentral.org","source":"Manual","datetime":"2024-12-05 13:00:13.000000","last_name":"Sotnik-Talisman","first_name":"Jenny"},{"email":"maorperlov@gmail.com","source":"Manual","datetime":"2022-04-12 10:59:40.000000","last_name":"Perlov","first_name":"Maor"},{"email":"maorperlov@gmail.com","source":"Manual","datetime":"2022-04-12 10:59:40.000000","last_name":"Perlov","first_name":"Maor"},{"email":"maorperlov@gmail.com","source":"Manual","datetime":"2022-04-12 13:09:22.000000","last_name":"Perlov","first_name":"Maor"},{"email":"maorperlov@gmail.com","source":"Manual","datetime":"2022-04-12 11:21:24.000000","last_name":"Perlov","first_name":"Maor"},{"email":"maorperlov@gmail.com","source":"Manual","datetime":"2022-04-12 10:58:59.000000","last_name":"Perlov","first_name":"Maor"},{"email":"maorperlov@gmail.com","source":"Manual","datetime":"2022-04-12 13:37:13.000000","last_name":"Perlov","first_name":"Maor"},{"email":"maorperlov@gmail.com","source":"Manual","datetime":"2022-04-12 11:00:48.000000","last_name":"Perlov","first_name":"Maor"},{"email":"maorperlov@gmail.com","source":"Manual","datetime":"2022-04-12 11:00:48.000000","last_name":"Perlov","first_name":"Maor"},{"email":"maorperlov@gmail.com","source":"Manual","datetime":"2022-04-12 13:37:14.000000","last_name":"Perlov","first_name":"Maor"},{"email":"maorperlov@gmail.com","source":"Manual","datetime":"2022-04-12 10:43:01.000000","last_name":"Perlov","first_name":"Maor"},{"email":"maorperlov@gmail.com","source":"Manual","datetime":"2022-04-12 10:42:56.000000","last_name":"Perlov","first_name":"Maor"},{"email":"maorperlov@gmail.com","source":"Manual","datetime":"2022-04-12 12:09:18.000000","last_name":"Perlov","first_name":"Maor"},{"email":"maorperlov@gmail.com","source":"Manual","datetime":"2022-04-12 12:09:18.000000","last_name":"Perlov","first_name":"Maor"},{"email":"maorperlov@gmail.com","source":"Manual","datetime":"2022-04-12 10:59:29.000000","last_name":"Perlov","first_name":"Maor"},{"email":"maorperlov@gmail.com","source":"Manual","datetime":"2022-04-12 10:59:29.000000","last_name":"Perlov","first_name":"Maor"},{"email":"maorperlov@gmail.com","source":"Manual","datetime":"2022-04-12 10:59:29.000000","last_name":"Perlov","first_name":"Maor"},{"email":"maorperlov@gmail.com","source":"Manual","datetime":"2022-04-12 10:59:29.000000","last_name":"Perlov","first_name":"Maor"},{"email":"maorperlov@gmail.com","source":"Manual","datetime":"2022-04-12 10:59:29.000000","last_name":"Perlov","first_name":"Maor"},{"email":"maorperlov@gmail.com","source":"Manual","datetime":"2022-04-12 11:34:13.000000","last_name":"Perlov","first_name":"Maor"},{"email":"maorperlov@gmail.com","source":"Manual","datetime":"2022-04-12 11:34:13.000000","last_name":"Perlov","first_name":"Maor"},{"email":"maorperlov@gmail.com","source":"Manual","datetime":"2022-04-12 11:34:13.000000","last_name":"Perlov","first_name":"Maor"},{"email":"maorperlov@gmail.com","source":"Manual","datetime":"2022-04-12 11:08:38.000000","last_name":"Perlov","first_name":"Maor"},{"email":"maorperlov@gmail.com","source":"Manual","datetime":"2022-04-12 11:02:16.000000","last_name":"Perlov","first_name":"Maor"},{"email":"maorperlov@gmail.com","source":"Manual","datetime":"2022-04-12 11:02:16.000000","last_name":"Perlov","first_name":"Maor"},{"email":"maorperlov@gmail.com","source":"Manual","datetime":"2022-04-12 11:01:32.000000","last_name":"Perlov","first_name":"Maor"},{"email":"maorperlov@gmail.com","source":"Manual","datetime":"2022-04-12 11:01:32.000000","last_name":"Perlov","first_name":"Maor"},{"email":"maorperlov@gmail.com","source":"Manual","datetime":"2022-04-12 13:36:20.000000","last_name":"Perlov","first_name":"Maor"},{"email":"maorperlov@gmail.com","source":"Manual","datetime":"2022-04-12 13:06:43.000000","last_name":"Perlov","first_name":"Maor"},{"email":"maorperlov@gmail.com","source":"Manual","datetime":"2022-04-12 11:00:00.000000","last_name":"Perlov","first_name":"Maor"},{"email":"maorperlov@gmail.com","source":"Manual","datetime":"2022-04-12 11:00:00.000000","last_name":"Perlov","first_name":"Maor"},{"email":"maorperlov@gmail.com","source":"Manual","datetime":"2022-04-12 13:37:14.000000","last_name":"Perlov","first_name":"Maor"},{"email":"maorperlov@gmail.com","source":"Manual","datetime":"2022-04-12 10:57:43.000000","last_name":"Perlov","first_name":"Maor"},{"email":"maorperlov@gmail.com","source":"Manual","datetime":"2022-04-12 11:10:43.000000","last_name":"Perlov","first_name":"Maor"},{"email":"maorperlov@gmail.com","source":"Manual","datetime":"2022-04-12 11:10:43.000000","last_name":"Perlov","first_name":"Maor"},{"email":"maorperlov@gmail.com","source":"Manual","datetime":"2022-04-12 11:10:43.000000","last_name":"Perlov","first_name":"Maor"},{"email":"maorperlov@gmail.com","source":"Manual","datetime":"2022-04-12 11:10:43.000000","last_name":"Perlov","first_name":"Maor"},{"email":"maorperlov@gmail.com","source":"Manual","datetime":"2022-04-12 11:15:01.000000","last_name":"Perlov","first_name":"Maor"},{"email":"maorperlov@gmail.com","source":"Manual","datetime":"2022-04-12 11:15:01.000000","last_name":"Perlov","first_name":"Maor"},{"email":"maorperlov@gmail.com","source":"Manual","datetime":"2022-04-12 11:15:01.000000","last_name":"Perlov","first_name":"Maor"},{"email":"maorperlov@gmail.com","source":"Manual","datetime":"2022-04-12 11:00:41.000000","last_name":"Perlov","first_name":"Maor"},{"email":"maorperlov@gmail.com","source":"Manual","datetime":"2022-04-12 11:00:41.000000","last_name":"Perlov","first_name":"Maor"},{"email":"maorperlov@gmail.com","source":"Manual","datetime":"2022-04-12 11:00:41.000000","last_name":"Perlov","first_name":"Maor"},{"email":"maorperlov@gmail.com","source":"Manual","datetime":"2022-04-12 13:33:41.000000","last_name":"Perlov","first_name":"Maor"},{"email":"maorperlov@gmail.com","source":"Manual","datetime":"2022-04-12 11:13:53.000000","last_name":"Perlov","first_name":"Maor"},{"email":"maorperlov@gmail.com","source":"Manual","datetime":"2022-04-12 11:13:53.000000","last_name":"Perlov","first_name":"Maor"},{"email":"maorperlov@gmail.com","source":"Manual","datetime":"2022-04-12 11:13:53.000000","last_name":"Perlov","first_name":"Maor"},{"email":"maorperlov@gmail.com","source":"Manual","datetime":"2022-04-12 11:08:39.000000","last_name":"Perlov","first_name":"Maor"},{"email":"maorperlov@gmail.com","source":"Manual","datetime":"2022-04-12 11:14:57.000000","last_name":"Perlov","first_name":"Maor"},{"email":"maorperlov@gmail.com","source":"Manual","datetime":"2022-04-12 13:04:57.000000","last_name":"Perlov","first_name":"Maor"},{"email":"maorperlov@gmail.com","source":"Manual","datetime":"2022-04-12 10:42:22.000000","last_name":"Perlov","first_name":"Maor"},{"email":"maorperlov@gmail.com","source":"Manual","datetime":"2022-04-12 13:33:15.000000","last_name":"Perlov","first_name":"Maor"},{"email":"maorperlov@gmail.com","source":"Manual","datetime":"2022-04-12 10:42:22.000000","last_name":"Perlov","first_name":"Maor"},{"email":"maorperlov@gmail.com","source":"Manual","datetime":"2022-04-12 10:42:22.000000","last_name":"Perlov","first_name":"Maor"},{"email":"maorperlov@gmail.com","source":"Manual","datetime":"2022-04-12 10:42:22.000000","last_name":"Perlov","first_name":"Maor"},{"email":"maorperlov@gmail.com","source":"Manual","datetime":"2022-04-12 10:42:22.000000","last_name":"Perlov","first_name":"Maor"},{"email":"maorperlov@gmail.com","source":"Manual","datetime":"2022-04-12 10:42:22.000000","last_name":"Perlov","first_name":"Maor"},{"email":"maorperlov@gmail.com","source":"Manual","datetime":"2022-04-12 10:42:22.000000","last_name":"Perlov","first_name":"Maor"},{"email":"maorperlov@gmail.com","source":"Manual","datetime":"2022-04-12 11:20:50.000000","last_name":"Perlov","first_name":"Maor"},{"email":"maorperlov@gmail.com","source":"Manual","datetime":"2022-04-12 11:20:50.000000","last_name":"Perlov","first_name":"Maor"},{"email":"eranl@sncentral.org","source":"Automatic","datetime":"2024-01-25 16:22:33.000000","last_name":"Levin","first_name":"Eran"},{"email":"eranl@sncentral.org","source":"Automatic","datetime":"2024-12-05 14:14:25.000000","last_name":"Levin","first_name":"Eran"},{"email":"jenny.sotnik@sncentral.org","source":"Manual","datetime":"2025-01-28 08:45:47.000000","last_name":"Sotnik-Talisman","first_name":"Jenny"},{"email":"jenny.sotnik@sncentral.org","source":"Manual","datetime":"2024-12-05 13:00:04.000000","last_name":"Sotnik-Talisman","first_name":"Jenny"},{"email":"jenny.sotnik@sncentral.org","source":"Manual","datetime":"2024-12-05 13:00:13.000000","last_name":"Sotnik-Talisman","first_name":"Jenny"},{"email":"maor.perlov@sncentral.org","source":"Manual","datetime":"2023-12-12 19:38:05.000000","last_name":"Perlov","first_name":"Maor"},{"email":"maor.perlov@sncentral.org","source":"Manual","datetime":"2023-12-12 19:40:21.000000","last_name":"Perlov","first_name":"Maor"},{"email":"maor.perlov@sncentral.org","source":"Manual","datetime":"2023-12-12 19:40:21.000000","last_name":"Perlov","first_name":"Maor"},{"email":"maor.perlov@sncentral.org","source":"Manual","datetime":"2023-12-12 19:40:22.000000","last_name":"Perlov","first_name":"Maor"},{"email":"eranl@sncentral.org","source":"Automatic","datetime":"2024-08-07 05:08:07.000000","last_name":"Levin","first_name":"Eran"},{"email":"maor.perlov@sncentral.org","source":"Manual","datetime":"2023-12-12 19:40:21.000000","last_name":"Perlov","first_name":"Maor"},{"email":"eranl@sncentral.org","source":"Automatic","datetime":"2024-01-25 08:03:03.000000","last_name":"Levin","first_name":"Eran"}],"sectorverify":null,"biverify":{"id":"agxzfmlsbGlzdHNpdGVyFQsSCE5ld19Vc2VyGICAoPu-g88JDA","fullname":"Maor Perlov"},"biverifydate":"2022-04-12T00:00:00.000Z","crunchbaseid":"lake-region-medical","lastupdator":"Jenny Sotnik-Talisman","lastupdator_email":"jenny.sotnik@sncentral.org","creator":"Maor Perlov","creator_email":"maorperlov@gmail.com","createdate":"2022-04-12T00:00:00.000Z","lastupdatedate":"2024-12-05","hide_reason":"7KVi9S7qqUtO0WCsFclwqBEZluejfNYqWC1Uhx0tPHtDxtvxPPaCPH","hide_reason_data":{"reason":"No longer active","visible":0},"logokey":"$2d3C4oFTmDCw4O7AhPPOvi8aPmOUOhMyhWMecqgAYhdZJPrbVH2Bna","name":"Integer Holdings Corporation","israeliacquisitions":1,"forbesranking":null,"investmentarm":null,"investmentarmname":null,"hubname":null,"acquired_amount":null,"acquired_by":null,"acquired_country":null,"acquired_month":null,"acquired_year":null,"type":"Multinational","formernames":["Accellent","Lake Region Medical"],"alternativenames":["Lake Region Medical","Greatbatch Medical"],"country":"United States","inisraelsince":"2/2020","inisraelsincemonth":"2","isisraeli":0,"marketcapital":2262431167,"marketcapitaldate":"2025-11-01T14:07:25.000Z","oneliner":"Medical Devices and Equipment and Supplies","website":"https://www.integer.net/","employees":"11-50","employees_exact":30,"employees_overall":"1,001-5,000","employees_overall_exact":3350,"sociallinks":{"twitter":"https://twitter.com/integerholdings","youtube":"","facebook":"","linkedin":"https://www.linkedin.com/company/10854676","instagram":""},"social":["https://www.linkedin.com/company/10854676","https://twitter.com/integerholdings"],"flattenedsociallinks":"https://www.linkedin.com/company/10854676|https://twitter.com/integerholdings","apps":{"appstore":"","googleplay":""},"investmentstage":[],"about":"Integer Holdings Corporation is one of the largest medical device outsource (MDO) manufacturers in the world serving the cardiac, neuromodulation, vascular and portable medical markets.\r\n\r\n The company provides innovative, high-quality technologies and manufacturing to Medical Device OEMs to enhance the lives of patients worldwide. In addition, it develops batteries for high-end niche applications in energy, military, and environmental markets. Greatbatch Medical Lake Region Medicaland Electrochem comprise the companys brands.\r\n\r\nIn 2020, Integer  has acquired Israeli medical device developer Inomec Ltd. The acquisition will allow Integer to set up an R&D and sales center in the region. The acquisition will also add important catheter design, clinical, and pilot manufacturing capabilities to its portfolio, and further position the company as a partner for innovative medical technologies.\r\n","founded":"1/1994","team":[{"name":"Eyal  Sandach ","email":"","phone":"","gender":"Male","userid":"agxzfmlsbGlzdHNpdGVyFQsSCE5ld19Vc2VyGICAkOKkwZ8KDA","bounced":false,"claimed":0,"founder":0,"urlname":"eyal-sandach-3","visible":1,"memberid":"agxzfmlsbGlzdHNpdGVyFwsSCk5ld19NZW1iZXIYgICQzOmI9gsM","position":"Country Manager","last_name":"Sandach ","claimtoken":"0a24c8d162278fe3240b6dadc0c0ce2e112c35f409d29e291f27188f3a742203","first_name":"Eyal ","picturekey":null,"claimeddate":null,"linkedinurl":"https://www.linkedin.com/in/eyal-sandach-364b433/","unsubscribed":false,"is_activeuser":1,"additionalemail":"","claimedemaildate":null,"initials":"ES","pictureurl":"/assets/empty-state.svg","linkedin-display":"flex","teammembertagclass":"none","teammembertagcontent":"","channelId":"","visibilityClassName":"","visibilityTooltip":""},{"name":"Aviad Yedgar","email":"","phone":"","gender":"Male","userid":"agxzfmlsbGlzdHNpdGVyFQsSCE5ld19Vc2VyGICAkKyYiJ0JDA","bounced":false,"claimed":0,"founder":0,"urlname":"aviad-yedgar-1","visible":1,"memberid":"agxzfmlsbGlzdHNpdGVyFwsSCk5ld19NZW1iZXIYgICQjM-pnQsM","position":"Director of Research & Development, IL Site","last_name":"Yedgar","claimtoken":"7a01b3897df310f0ee219a948db852e2a24ffb78b825ca7830e62cfb0b70ab7c","first_name":"Aviad","picturekey":null,"claimeddate":null,"linkedinurl":"https://www.linkedin.com/in/aviad-yedgar/","unsubscribed":false,"is_activeuser":1,"additionalemail":"","claimedemaildate":null,"initials":"AY","pictureurl":"/assets/empty-state.svg","linkedin-display":"flex","teammembertagclass":"none","teammembertagcontent":"","channelId":"","visibilityClassName":"","visibilityTooltip":""}],"portfolio":[{"name":"Inomec","hidden":true,"raised":"Undisclosed","founded":"2009","fullurl":"/company_page/inomec","logokey":"$GLTIlxTfiaQUD9oWIPs3fEKDSadH8K6I3DyhpLpu8m8UCTQxHy0Tdj","urlname":"inomec","employees":"11-50","company_id":"agxzfmlsbGlzdHNpdGVyGAsSC05ld19Db21wYW55GICA4JbCmMwJDA","description":"Research, Development, and Manufacturing of Medical Devices","fundingstage":"Acquired","businessmodel":"B2B","raisedNumber":0,"logourl":"https://storage.googleapis.com/clean-finder-353810/$GLTIlxTfiaQUD9oWIPs3fEKDSadH8K6I3DyhpLpu8m8UCTQxHy0Tdj","style":"","hiddenCompanyTooltip":""}],"exits":[],"mediagallery":[],"affiliatedOrganizations":null,"address":{"israeli":[{"id":"4835a4d2-7086-41f3-8c84-dd6cc0d09e0d","city":"Netanya","type":["R&D","Sales"],"address":"Netanya, Israel","placeid":null,"notactive":1,"openeddate":"2020-02-01","registrarid":"514316579","firstrdcenter":0,"registrarname":"KANAF INNOVATIONS LTD"}],"officesabroad":[{"id":"V8Zb0KINfsBlMTDYm5Q0dUli7BJumiia2H9776XLxXN7QCIJTKAvGD","city":"Plano","address":"Plano, TX, USA","country":"United States","placeid":"ChIJE5XFE9ohTIYRK2DNiWQDqmI"}]},"headquarter_address":"Plano, TX, USA","news":[{"id":"lXRFyy104IupJqTUWELbEOF9THw6ut0fVZ7DC2JJts3oljBlDg04XW","date":"Jul 11, 2025","link":"https://finance.yahoo.com/news/inspiremd-launches-cguard-prime-carotid-135700508.html","source":"finance.yahoo.com","visible":1,"analysis":{"tags":"stroke prevention","round":null,"company":"InspireMD, Inc.","layoffs":null,"summary":"InspireMD, Inc. has launched its CGuard Prime Carotid Stent System in the U.S. after receiving FDA premarket application approval. This launch is a significant milestone for the company, as it introduces its advanced stroke prevention technology to the U.S. market. The CGuard Prime system, featuring proprietary MicroNet mesh technology, aims to provide sustained embolic protection and reduce stroke risks. Despite a recent decline in share prices, the launch is expected to drive revenue growth and expand market share. InspireMDs market capitalization stands at $74.4 million, and the company is well-positioned to capture a significant portion of the U.S. carotid stenting market.","partners":null,"customers":null,"eventType":null,"investors":null,"confidence":10,"key_topics":["CGuard Prime","FDA approval","U.S. launch","stroke prevention","MicroNet technology"],"date_of_event":"recently","product_stage":"released","investment_date":null,"acquired_company":null,"valuation_amount":"$74.4 million","impact_on_company":"growth-positive","investment_amount":null,"structured_issues":["Product Stage","FDA approved/pending approval"],"acquisition_amount":null,"FDA approved/pending approval":"approved","AI technology developing/using":"using","structuredIssuesShow":"#Product Stage  #FDA approved/pending approval","entityGrowthIconPath":"url(/assets/circle-green.svg);"},"sentiment":"growth-positive","analysisId":"7CsPfQu47eW1maT3uUlugJxTVMEGvbhwDmUL8RrFTWZNt97trOBaQ4","news_summary":"InspireMD Launches CGuard Prime Carotid Stent System in the U.S.","analysisStructuredIssuesDisplay":"block","analysisImpactOnCompanyDisplay":"block"},{"id":"RSRO0h6UFv6KFhm7ohelLXpsP5MeTgutPSswFz1EhKJix6jz4aZK8c","date":"Jun 6, 2025","link":"https://finance.yahoo.com/news/nvcr-stock-dips-despite-positive-162600550.html","source":"finance.yahoo.com","visible":1,"analysis":{"tags":"clinical trial","round":null,"company":"Novocure","layoffs":null,"summary":"Novocure recently announced positive results from its Phase 3 PANOVA-3 trial, which evaluated the efficacy of Tumor Treating Fields (TTFields) therapy combined with gemcitabine and nab-paclitaxel for treating unresectable, locally advanced pancreatic cancer. The trial met its primary endpoint, showing a significant improvement in overall survival compared to standard chemotherapy. These results support the potential expansion of TTFields therapy beyond glioblastoma and mesothelioma, potentially leading to regulatory submissions in major markets. Despite a recent decline in share price, the positive trial outcomes could enhance Novocures long-term business prospects by enabling entry into the pancreatic cancer market, driving revenue growth, and improving reimbursement prospects.","partners":null,"customers":null,"eventType":null,"investors":null,"confidence":9,"key_topics":["PANOVA-3","TTFields","pancreatic cancer","survival","chemotherapy"],"date_of_event":"May 31","product_stage":"clinical trial","investment_date":null,"acquired_company":null,"valuation_amount":"$1.86 billion","impact_on_company":"growth-positive","investment_amount":null,"structured_issues":["Product Stage"],"acquisition_amount":null,"FDA approved/pending approval":"pending approval","AI technology developing/using":null,"structuredIssuesShow":"#Product Stage","entityGrowthIconPath":"url(/assets/circle-green.svg);"},"sentiment":"growth-positive","analysisId":"QDO93hKrPGFg7t9IaQK9cJspK28IdR9viaVYnU9tVBhbeAUcrDoNiA","news_summary":"NVCR Stock Dips Despite Positive OS Data From Phase 3 PANOVA-3 Trial","analysisStructuredIssuesDisplay":"block","analysisImpactOnCompanyDisplay":"block"},{"id":"nC4bZaCXBcSmVrk2VuAhwvtkh6nrKzWdZKrzaAj4CK38gfl7GYFwgM","date":"Dec 10, 2023","link":"https://www.themarker.com/technation/2023-12-10/ty-article/.premium/0000018c-5378-df2f-adac-ff7def480000","source":"www.themarker.com","visible":1,"analysis":{"tags":"Closure, Layoffs","company":"Integer Holdings Corporation","layoffs":"35","summary":"American medical equipment company Integer Holdings Corporation is closing its Israeli development center and laying off its 35 employees. The center, managed by Eyal Sandetz, was based on the acquisition of the Israeli Inomec in early 2020, and it will cease to exist in three weeks.","partners":"NA","customers":"NA","investors":"NA","confidence":"10","key_topics":["Medical Equipment","Closure","Layoffs"],"date_of_event":"10 December 2023","valuation_amount":"NA","impact_on_company":"Growth-Negative","investment_amount":"NA","structured_issues":["Layoffs"],"acquisition_amount":"NA","structuredIssuesShow":"#Layoffs","entityGrowthIconPath":"url(/assets/circle-red.svg);"},"sentiment":"Growth-Negative","analysisId":"3wyOxsewrWmQgDFRTv7euxeOHl36OZdyIBkOjxnWdKI6e4caTjalTO","news_summary":"\"שיקוף של מצב הסטארט-אפים בתחום\": אינטג'ר יוצאת מישראל","analysisStructuredIssuesDisplay":"block","analysisImpactOnCompanyDisplay":"block"},{"id":"f8066660-672a-475e-b8b6-08a9e70b76e2","date":"Feb 19, 2020","link":"https://en.globes.co.il/en/article-integer-buys-israeli-medical-device-co-inomec-1001319119","source":"en.globes.co.il","visible":1,"analysis":{"tags":"Acquisition, Expansion","company":"Inomec","layoffs":"Not mentioned","summary":"US medical device outsource manufacturer Integer Holdings Corporation has acquired Israeli medical device developer Inomec. The acquisition will allow Integer to set up an R&D and sales center in Israel, adding important catheter design, clinical, and pilot manufacturing capabilities to its portfolio. Inomec specializes in R&D and manufacturing medical devices, including minimally invasive tools, delivery systems, metal implants, drug-device combination devices, and laser processing services. The new center will enable Integer to be surrounded by an extensive pipeline of early and late stage startups as well as multinational medtech companies located in Israel.","partners":"Not mentioned","customers":"Not mentioned","investors":"Integer Holdings Corporation","confidence":9,"key_topics":"Acquisition, Medical Device, R&D, Sales Center, Innovation","date_of_event":"February 20, 2020","valuation_amount":"Not mentioned","impact_on_company":"growth-positive","investment_amount":"Not mentioned","structured_issues":"Acquisition, Expand","acquisition_amount":"Not mentioned","structuredIssuesShow":"#Acquisition, Expand","entityGrowthIconPath":"url(/assets/circle-green.svg);"},"sentiment":"growth-positive","analysisId":"cguRRkrAs3fvfYu261ePH4bLlB1Gd0kRMoRrRvhK1LpH0gvqEeRR0w","news_summary":"Integer buys Israeli medical device co Inomec","analysisStructuredIssuesDisplay":"block","analysisImpactOnCompanyDisplay":"block"}],"extensions":null,"events":null,"hide_reasons":[{"id":"75T5aG1f0dpqYFonup40lXNjO046zUH82TaHW1TAiIMf9aYAsSOl0d","reason":"No relevant activity"},{"id":"7KVi9S7qqUtO0WCsFclwqBEZluejfNYqWC1Uhx0tPHtDxtvxPPaCPH","reason":"No longer active"},{"id":"hoyKAmu4YJEHmhtLwCdeFldSnDwaVbPXOnH0RA9hKHCzAcHO6OOrXd","reason":"Pending approval"},{"id":"TC54H7CXyKO8GmPECkbyKJf8n34r70JlfJTJHfo85exRpLaKI1Efs9","reason":"Pending approval - External entity"}],"timeline":[{"id":"agxzfmlsbGlzdHNpdGVyFgsSCUJhc2VFdmVudBiAgJCMz73CCAw","hub":null,"date":"2020-09-01","batch":"","token":"","amount":null,"hub_id":null,"source":"","ticker":"ITGR","enddate":"","mnatype":null,"eventtype":"POEvent","granttype":null,"valuation":null,"investment":[],"hub_logokey":null,"hub_urlname":null,"wasacquired":null,"delistreason":null,"capitalraised":null,"stockexchange":"NYSE","eventvisibility":"Public","amountvisibility":null,"duetoacquisition":null,"isextensionround":null,"token_visibility":"","fundingvisibility":null,"stockexchange_key":"agxzfmlsbGlzdHNpdGVyHAsSD0V4dGVybmFsX0VudGl0eRiAgODIgdygCww","acquiredcompany_mna":null,"communitycompany_id":null,"isjointventuregrant":null,"acquiredcompany_spac":"Undisclosed","communitycompany_name":null,"communitycompany_type":null,"stockexchange_logokey":"$gCUzHIIl5WdaUySSBVfr4ukCJPjuwKJMFXjiY09JCLUNERZRom14T0","acquiredcompany_mna_id":null,"fundingtypefundingtype":null,"acquiredcompany_reverse":null,"acquiredcompany_spac_id":null,"communitycompany_hidden":null,"communitycompany_fullurl":null,"communitycompany_logokey":null,"communitycompany_urlname":null,"acquiredcompany_reverse_id":null,"acquiredcompany_mna_logokey":null,"acquiredcompany_mna_urlname":null,"acquiredcompany_mna_homepage":null,"acquiredcompany_spac_logokey":null,"acquiredcompany_spac_homepage":null,"acquiredcompany_reverse_logokey":null,"acquiredcompany_reverse_urlname":null,"acquiredcompany_reverse_homepage":null,"hub_logourl":"/assets/empty-state.svg","stockexchange_logourl":"https://storage.googleapis.com/clean-finder-353810/$gCUzHIIl5WdaUySSBVfr4ukCJPjuwKJMFXjiY09JCLUNERZRom14T0","communitycompany_logourl":"/assets/empty-state.svg","acquiredcompany_mna_logourl":"/assets/empty-state.svg","acquiredcompany_spac_logourl":"/assets/empty-state.svg","acquiredcompany_reverse_logourl":"/assets/empty-state.svg","style":"","hiddenCompanyTooltip":""}],"techcommunityinvolvement":null,"tags":["medical-devices","cardiology","vascular"],"investments":[],"funds":[],"databases":[],"sharedspaces":[],"utilities":[],"contributors":[],"employeesworldwide":"1,001-5,000","fundingtype":"Multinational","parsedName":"Integer Holdings Corporation","logourl":"https://storage.googleapis.com/clean-finder-353810/$2d3C4oFTmDCw4O7AhPPOvi8aPmOUOhMyhWMecqgAYhdZJPrbVH2Bna","oglogourl":"https://storage.googleapis.com/clean-finder-353810/$2d3C4oFTmDCw4O7AhPPOvi8aPmOUOhMyhWMecqgAYhdZJPrbVH2Bna","teamMembersNumber":2,"nationality":"Foreign","communityinvolvement":[],"popup_claim_profile":"false","claimedBadge":"none","display":{"mainContact":"none"},"mainContact":{},"_eventview":{"publicoffering_exit":[],"privateequityfunding":[],"nonequityfunding":[],"merger_acquisitions":[],"others":[]}}